Recall Register

Food, drugs, devices › Volcano Corporation

Device recall: Philips Volcano CORE M2 Vascular System, Part # 400-0100.17, Rx Only. Used for the qualitative and quantitative evaluati

FDA enforcement event 79715 · Class II · initiated 22 Mar 2018 · status Terminated · terminated 28 Apr 2021

DeviceVoluntary: Firm initiated1 product recordRancho Cordova, CA

Volcano Corporation (Rancho Cordova, CA) initiated this device recall on 22 Mar 2018; FDA lists 1 product record under event 79715, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 92% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 28 Apr 2021. Initiation: voluntary: firm initiated. Volcano Corporation has 13 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Volcano Corporation, Rancho Cordova, CA.

Reason for recall

"The incorrect resistor has been used in affected CORE M2 Imaging Systems, which causes noise and results in an overly bright IVUS Image."

Distribution

"Worldwide Distribution -- U.S., to the states of California, Connecticut, Tennessee, North Carolina, Maryland, and Oregon; and, the country of Australia."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1891-2018Philips Volcano CORE M2 Vascular System, Part # 400-0100.17, Rx Only. Used for the qualitative and quantitative evaluation of vascular morphology in the coronary arteries and vessels of the peripheral vasculature.8 devicesClass IITerminated23 May 2018

Context

92%of 2018 device events are Class II1,074 events that year
1product record in this eventfirm median: 1
13events on this register for the firm

Other enforcement events for Volcano Corporation

InitiatedProduct (first record)TypeClassRecords
19 Jan 2022SyncVision Systems, Model: 400-0100.10, PN: 30000485688x, with software version 4.2.xDeviceClass II1
7 Nov 2018Philips Volcano FFR software used in the following systems connected to the McKesson, Schwarzer, and some Philips Xper HDeviceClass II1
17 Oct 2018Visions PV .035 Digital IVUS Catheter, Catalog Number/Part Number 88901/400-0200.173 Product Usage: The Volcano PV .035 DeviceClass II2
3 Nov 2017Volcano Imaging System s5i REF 807400001; CORE Mobile Imaging System (120V) REF 400-0100.01; CORE Mobile Imaging System DeviceClass II1
29 Mar 2017Refinity Rotational Intravascular Ultrasound (IVUS) Catheter; Product number: 400-0200.289; Catalog number 89800. CardioDeviceClass II2
25 Apr 2016Volcano s5, s5i, CORE and CORE Mobile systems with software version 3.4 and v3.4 software kits. Cardiology: The Volcano DeviceClass II1
5 Feb 2016Volcano R100 Sterile Equipment Cover; Sterile; General Hospital: These Sterile Equipment covers are provided to cover eqDeviceClass II2
22 Jul 2015Volcano Pioneer Plus Re-Entry Catheter; Product Code PPLUS20, Catheter for Crossing Total Occlusions. Cardiovascular: ThDeviceClass II1
22 Jun 2015Volcano s5/s5i/CORE Intravascular Ultrasound Systems with software versions 3.3 and 3.4 (with and without iFR Scout TechDeviceClass II6
4 Jun 2015Volcano PV .035 Catheter: Part number: 88901; Product Usage: The Volcano PV .035 is indicated for use in the evaluation DeviceClass II2

All 13 events for Volcano Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The incorrect resistor has been used in affected CORE M2 Imaging Systems, which causes noise and results in an overly bright IVUS Image."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution -- U.S., to the states of California, Connecticut, Tennessee, North Carolina, Maryland, and Oregon; and, the country of Australia."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Apr 2021. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.